Join to View Full Profile
521 N Lecanto HwyFlorida Cancer Specialists P LLecanto, FL 34461
Phone+1 352-746-0707
Fax+1 352-746-6333
Dr. Fonseca is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1992 - 1995
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1988 - 1992
Universidad del Norte Faculty of MedicineClass of 1986
Certifications & Licensure
FL State Medical License 1990 - 2027
TX State Medical License 1993 - 2013
LA State Medical License 1995 - 2012
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2014
Clinical Trials
Publications & Presentations
PubMed
- Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014.Nizar J Bahlis, Christy Samaras, Donna Reece, Michael Sebag, Jeffrey Matous
Clinical Lymphoma, Myeloma & Leukemia. 2024-12-01 - 33 citationsPhase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy.Anthony R. Mato, Nilanjan Ghosh, Stephen J. Schuster, Nicole Lamanna, John M. Pagel
Blood. 2021-05-20 - 59 citationsPomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatmentDavid S. Siegel, Gary J. Schiller, Christy J. Samaras, Michael Sebag, Jesus G. Berdeja
Leukemia. 2020-05-06
Press Mentions
Florida Cancer Specialists & Research Institute Real-World Evidence Capabilities Contributing to Breakthroughs in Blood Cancer Treatment WorldwideSeptember 24th, 2024- Florida Cancer Specialists & Research Institute Leverages Real-World Evidence Capabilities to Advance Blood Cancer TreatmentSeptember 7th, 2024
- Florida Cancer Specialists & Research Institute Studies Featured at ASCO® 2021 Annual MeetingJune 3rd, 2021
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish, German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
